Harry Kirsch became group chief financial officer of Novartis on 1 May, taking over from Jon Symonds. He was previously CFO of the pharmaceuticals division. Mr Kirsch joined Novartis in 2003 having previously been CFO of the Procter & Gamble Company’s global pharmaceuticals business.
Novartis announced the appointment on 24 April 2013.
Copyright 2013 Evernow Publishing Ltd